arsenic are well documented in animal experiments. Administration of high doses of arsenite or arsenate to rodents prior to or during organogenesis results in multiple malformations, decreased prenatal growth rate, and increased mortality (Ferm et al, 1971; Hood and Bishop, 1972; Beaudoin, 1974; Hood et al, 1978; Morrissey and Mottet, 1983; Nagymajtenyi et al, 1985; Ferm and Hanlon, 1985) . In particular, neural tube defects appear to be a consistent outcome (Morrissey and Mottet, 1983; Willhite and Ferm, 1984; Golub, 1994) .
Despite the large number of people being exposed throughout their life, however, there are very few data on the reproductive effects of arsenic in humans. In a couple of studies, prenatal exposure to acute, very high doses of arsenic has resulted in miscarriage and early neonatal death (Lugo et al, 1969; Bolliger et al, 1992 ). An increased frequency of malformations, spontaneous abortions, and low birth weights has been observed among children of female employees in a copper smelter (Nordstrom et al, 1979a, b) , but due to the multiple chemical exposure the role of arsenic is not clear. There are also a few reports indicating associations between adverse reproductive outcome and exposure to arsenic in drinking water (Zierler et al, 1988; Aschengrau et al, 1989; Borzsonyi et al, 1992) ; however, the causal relationship is not well ascertained. Data on placental transfer of arsenic in cases of no apparent maternal toxicity are even more scarce. In women without known exposure to arsenic, the concentration of arsenic in cord blood was similar to that in maternal blood (Kagey et al, 1977) . However, the form of arsenic in blood was not determined. The main exposure form of arsenic in food is arsenobetaine, which can be present in high concentrations in various seafood (Edmonds and Francesconi, 1987) and give rise to elevated blood arsenic concentrations (Foa et al, 1984; Yamauchi etal, 1992) . This form of arsenic is rapidly excreted in the urine and much less toxic than inorganic arsenic (Vahter etal, 1983) .
We have recently reported on high concentrations of arsenic in blood and urine of native Andean women and children living in an area in northern Argentina with about 200 /ig As/liter in the drinking water (Vahter et al, 1995a; Concha etal, 1998a) , although they showed less of the metabolite methylarsonic acid (MMA) in the urine compared with previous human studies. Inorganic arsenic is methylated in the body to MMA and dimethylarsinic acid (DMA) (for review see Vahter and Marafante, 1988) . The methylated metabolites are less reactive with tissue constituents, less toxic, and more rapidly excreted in the urine than inorganic arsenic (Buchet et ai, 1981a; Moore etal., 1997) .
The aim of the present study was to investigate exposure to arsenic during early development by comparing concentrations and patterns of arsenic metabolites in cord blood and infant urine with those of maternal blood and urine.
MATERIAL AND METHODS
The study was conducted in San Antonio de los Cobres, located at an altitude of 3.800 m above sea level in the western part of the Salta province in northern Argentina. The village has about 4000 inhabitants, mainly indigenous (Bennet, 1947) . Due to the high content of arsenic in the volcanic bedrock, the groundwater used for drinking contains about 200 /xg/liter (Vahter et ai, 1995a) . The nutritional basis of the population is mainly of animal origin (meat and milk products, but essentially no fish), supplemented with vegetables, maize, and rice. According to the hospital statistics, about 200 children are born a year. Most of them are delivered at the hospital, which also provides antenatal and neonatal health care. About 30% of the children 0-2 years of age and 8% of the children 2-5 years of age suffer from malnutrition. The mortality rate is about 50 per thousand for children below 1 year of age.
In total, 11 women in late gestation were recruited at the antenatal center of the hospital. One woman had complications after delivery and had to be transferred to another hospital. One infant died of pneumonia 2 months after the birth. For investigation of arsenic exposure, samples of maternal blood and urine were collected before delivery, cord blood and placenta were collected at delivery, and samples of maternal blood, urine, and breast milk were collected at an average of 2.8 weeks, 2.5 months, and 4.4 months after delivery. In addition, infant urine were collected a few days after birth (the very first urine produced), as well as 2.8 weeks, 2.5 months, and 4.4 months, on average, after birth.
Blood samples were collected from the arm vein (cubital) using Venoject tubes (VP-100SDK, Terumo, Leuven Belgium) with EDTAtKJ as anticoagulant. Cord blood was obtained from the umbilical artery as soon as possible after delivery. Placentas were collected in plastic bags and deep-frozen. Spot urine samples were collected in acid-washed plastic containers and transferred to 60-ml acid-washed polyethylene bottles. For the infants, baby urine collectors were used. The pH of the urine and the presence of glucose and protein were tested immediately after sampling using N-Combur-Test (BoeringerMannheim, Mannheim, Germany). Milk samples were collected by manual expression into washed plastic containers and transferred to 60-ml acid-washed bottles. All samples were frozen and kept at -20°C until they were transported (on wet ice) to Sweden for analysis. Each woman was interviewed about the time of residence in the area as well as the source of drinking water, water consumption, and dietary habits. Neonatal parameters, such a gender, weight, and length, were recorded.
The concentrations of total arsenic in blood, urine, and milk were determined using hydride generation atomic absorption spectrophotometry (HG-AAS), following dry ashing (Vahter and Lind, 1986; Tarn and Conacher, 1977; Tam and Lacroix, 1982) . The same procedure was used for analysis of placentas after they had been homogenized using a food processor. The concentrations in urine were adjusted for variation in density, determined by a Goldberg refractometer. The sum of the metabolites of inorganic arsenic (U-As^; inorganic arsenic, MMA, and DMA) in the urine samples was determined using direct HG-AAS after addition of HO to 0.6 M. Separation of the different metabolites of inorganic arsenic in urine and plasma was performed using ion-exchange chromatography on columns of Bio-Rad AG 50 WX-8 resin, according to the method of Tam et at (1978) , by which inorganic Before delivery 2.8 weeks postpartum 2.5 months postpartum 4.4 months postpartum " B-As, blood arsenic concentration; U-As,^, urinary arsenic metabolites. 6 Adjusted to a density of 1.014 g/ml (average of all urine samples). c Median (range).
arsenic, MMA, and DMA are eluted sequentially with 0.5 M HC1, deionized water, 1 M NH 4 0H, and 4 M NH 4 OH (for details, see Vahter et al., 1995a) . The arsenic concentrations in the milk were too low for speciation. The detection limit of the HG-AAS method was, on average, 1.6 ng (SD 0.66).
For quality control (QC) purposes, Standard Reference Water (1643c, NIST, USA) and Standard Reference Material 2670 (Toxic Metals in Freeze-Dried Urine) were analyzed for total arsenic (certified concentrations 82 ± 1.2 and 480 ± 100 /ig/liter, respectively) together with the collected blood and unne samples. The average concentrations obtained were 86 jxg/liter (SD 4.2, N = 56) and 524 tig/liter (SD 51, N = 25). The milk samples were analyzed together with IAEA Milk Powder A: 11. The result obtained was, on average, 5.3 /xg/kg (SD 1 2, N = 10); the recommended value, 4.85 /xg/kg. In addition 12 maternal blood samples and 9 cord samples were spiked with 7.9 ng As/g (SD 0.19) and 17 ng As/g (SD 1.8), and 15 human milk samples were spiked with 5.4 ng As/g (SD 0.13) and 11.2 ng As/g (SD 1 5) with Standard Reference Water. The average recovery in the blood samples for respectively concentration was 100 and 94% (range, 75-112%); in the milk the recovery was 98 and 107%, respectively (range, 78-121%).
For statistical analysis, the Mann-Whitney rank sum test. Spearman rank order correlation test, and Pearson product moment correlation were used.
RESULTS
The concentration of arsenic in cord blood (median, 9.0 /xg/liter; range, 6.0-12 /xg/liter) was almost as high as that in maternal blood in late gestation (median 11 /xg/liter, Table 1 ). As shown in Fig. 1 , there was a significant association between arsenic concentrations in maternal and cord blood (r 2 = 0.62, p = 0.004). The median arsenic concentration in the placenta was 34 /xg/kg wet wt (range, 17-54 /xg/kg, N = 11).
Maternal blood arsenic concentration (B-As) increased significantly from about 11 /xg/liter at delivery to about 16 /xg/ liter 4.4 months postpartum (p = 0.015; Table 1 ). In contrast, U-ASn^ was slightly higher in late gestation compared with the postpartum period. There was a significant correlation between maternal B-As and U-As,^, 2.8 weeks and 2.5 months postpartum (r 2 = 0.57, p = 0.009, and r 2 = 0.69, p = 0.005, respectively), but not in late gestation and 4.4 months postpartum (r 2 = 0.28, p = 0.088, and r 2 = 0.22, p = 0.186). In general, the concentrations of total arsenic in maternal milk were low, on average 3.1 /xg/kg (Table 2 ). There was no change in the concentrations during the lactation period. There was no association between arsenic concentrations in maternal blood and breast milk. In the infants, U-As mct decreased significantly (p = 0.025) during the first 4.4 months of life (Fig. 2) . The average concentration of UAs met in the infants at birth (range, 51-196 /xg/liter) constituted 23% of that in maternal urine, but only 9% at 4.4 months after birth (range, 13-98 /xg/liter). Five infants receiving breast milk only had significantly lower U-As met (median, 17 /xg/liter) than those fed formula in addition to breast milk (median, 103 /xg/liter; p = 0.036).
As shown in Table 3 , essentially all the arsenic in the blood plasma of women in late gestation, as well as their newborns, was present as DMA. Very few samples had detectable amounts of inorganic arsenic and/or MMA. DMA was the major form of arsenic also in maternal urine before parturition and in the first infant urine after birth (Table 4 ). There was a significant decrease in the percentage DMA in maternal urine from late gestation to 4.4 months postpartum (p < 0.001). The concentrations of arsenic in most urine samples of the infants a couple of weeks or more after birth were too low for speciation. Also, the arsenic concentrations in milk were too low for speciation.
The body weight at birth was 3000 g on average (range, 
2000-3750 g
). Only two infants weighed less than 2500 g at birth. There was no significant association between the arsenic concentrations in maternal blood or cord blood and body weight at birth (r 2 = 0.27, p = 0.088, and r 2 = 0.07, p = 0.400, respectively). Neither was there any gender difference in the percentage arsenic metabolites in the first urine of the infants.
DISCUSSION
The concentrations of arsenic in cord blood, 9.2 pig/liter on average, were about as high as in maternal blood just before delivery. This shows that arsenic is readily transferred across the placenta to the fetus. The blood arsenic concentrations were clearly elevated. For comparison, the blood arsenic concentration in people with no known exposure to arsenic is about 1 /xg/liter (Concha et ai, 1998a ).
An important finding was that essentially all arsenic in maternal and cord plasma was in the form of DMA, the end product of inorganic arsenic metabolism. Also, the percentage DMA in maternal urine in late gestation and first infant urine was significantly higher than in the postpartum period. Previous reports on urinary arsenic metabolites in human subjects exposed to inorganic arsenic show consistently average values of 60 to 70% DMA (see, e.g., the review by Hopenhayn-Rich et ai, 1993) . Thus, the results indicate that arsenic methylation increases during pregnancy and that DMA is the main form of arsenic being transferred to the fetus. This is important from a toxicological point of view, as DMA is much less toxic to the embryo and fetus than inorganic arsenic. In studies on mice ' <d.l., under detection limit and hamsters, about 10 times higher doses of DMA than of inorganic arsenic were required to induce malformations (Rogers et al, 1981; Hood et al, 1982) . Our previous studies in the Andean village have indicated that the children excrete less DMA in the urine, indicating that they are more sensitive to arsenic-induced toxicity than are the adults (Concha et al, 1998a) . If so, the increased arsenic methylation during pregnancy is highly protective for the developing organism.
An increased rate of methylation of arsenic may explain the observed lower B-As and higher U-As met in late gestation, compared with the postpartum period or with nonpregnant women in the same area (Vahter et al, 1995a) . DMA has a higher rate of excretion and lower tissue retention than inorganic arsenic (Buchet et al, 1981a, b; Vahter et al, 1984; Marafante et al, 1987) . However, the mechanism of the increased arsenic methylation is not clear. The arsenite methyltransferase has not been fully characterized, but has been isolated from tissues of several mammalian species, e.g., rabbit, rat, mouse, hamster, pigeon, and rhesus monkey, which also methylate arsenic in vivo (Aposhian et al, 1997) . Enzyme activity could not be detected in the liver of the marmoset monkey and chimpanzee (Aposhian et al, 1997) , which is in agreement with the lack of arsenic methylation in these species (Vahter and Marafante, 1985; Vahter et al, 1995b) . There are no reports on such enzyme activity in human tissues, but, so far, all human populations studied excrete MMA and DMA in urine, giving strong support for methylation being an enzymatic process also in humans. If so, the results of the present study might indicate an induction of the arsenite methylation. Interestingly, the activity of several methyltransferases increases during pregnancy, probably because several endogenous methylation reactions, e.g., DNA methylation and protein methylation, are crucial for normal mammalian development (Paik etal, 1991; Jaenisch, 1997) .
The median arsenic concentration in placenta was 34 /xg/kg wet wt, i.e., about three times the blood concentration. Women living close to a smelter in Bulgaria had an average arsenic concentration in placenta of 23 /xg/kg, as compared with 7 jig/kg in a nonsmelter area (Tabacova et al, 1994) . The effect of arsenic accumulation on placental function is not known.
Despite the high arsenic concentrations in maternal blood and urine, the concentration in maternal milk was low, on average 3.4 /xg/kg. This is similar to a previous finding on arsenic concentrations in maternal milk (Concha et al., 1998b) . As a result of breastfeeding milk with low arsenic concentrations, U-ASn^, concentrations in newborn infants decreased slowly during the first 4.4 months after birth. The highest U-ASn^, concentrations were detected in three infants who were given formula in addition to breast milk. It can be calculated that breastfeeding provides about 3 p,g arsenic per day, while formula prepared from the local water would provide about 200 /xg arsenic/day. Thus, the low content of arsenic in maternal milk is an additional important reason for long breastfeeding periods in areas with high arsenic exposure.
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